Sort   by:  
 Page size 
UnknownCHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin.
Not available
S-EPMC8209271 | biostudies-literature
UnknownDynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer.
Not available
S-EPMC4563784 | biostudies-literature
UnknownDual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells.
Not available
S-EPMC8833549 | biostudies-literature
UnknownA BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
Not available
S-EPMC4412825 | biostudies-literature
UnknownTargeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
Not available
S-EPMC6989400 | biostudies-literature
UnknownEffective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51.
Not available
S-EPMC8993694 | biostudies-literature
UnknownPTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.
Not available
S-EPMC5318947 | biostudies-literature
UnknownOrthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.
Not available
S-EPMC11150407 | biostudies-literature
UnknownA novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.
Not available
S-EPMC4864432 | biostudies-literature
UnknownConvergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.
Not available
S-EPMC5898430 | biostudies-literature
Sort   by:  
 Page size